Affiliation:
1. From the Unità Operativa Determinanti Biomolecolari nella Prognosi e Terapia; Statistica Medica e Biometria; Unità di Chirurgia Ginecologica; Unità di Anatomia PatologicaIstituto Nazionale per lo Studio e la Cura dei Tumori; Istituto di Statistica Medica e Biometria, Università degli Studi; and Centro per lo Studio della Patologia Cellulare, Consiglio Nazionale delle Ricerche, Milan, Italy.
Abstract
PURPOSE: To analyze the time-dependent prognostic role of the investigated variables, considered, when appropriate, on a continuous scale, for the purpose of evaluating and describing the interrelationships between clinically relevant patient and tumor characteristics (age, size and histology, and estrogen receptor [ER] and progesterone receptor content) and the risk of new disease manifestation. PATIENTS AND METHODS: We applied a flexible statistical model to a case series of 1,793 patients with axillary lymph node–negative breast cancer with a minimal potential follow-up of 10 years. To avoid a potential confounding effect of adjuvant treatment, only patients given local-regional therapy until relapse were considered. RESULTS: ER content and tumor size (adjusted for all the other covariates) showed a time-dependent relationship with the risk of new disease manifestations. In particular, ER content failed to show a prognostic effect within the first years of follow-up; thereafter, a positive association with risk of relapse was observed. For tumor size, within the first years of follow-up, the risk of relapse was directly related to size for only tumors up to 2.5 cm in diameter; thereafter, the impact on prognosis progressively decreased. CONCLUSION: The availability of a long follow-up on a large breast cancer series, as well as the use of innovative statistical approaches, allowed us to explore the functional relation between steroid receptors and clinical outcome and to generate a hypothesis on the involvement of ER in favoring long-term metastasis development.
Publisher
American Society of Clinical Oncology (ASCO)
Reference41 articles.
1. De Sombre ER, Smith S, Block GE, et al: Prediction of breast cancer response to endocrine therapy. Cancer Chemother Rep 58:5113,1974-5119,
2. Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis
3. Knight WA, Livinston RB, Gregory EJ, et al: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669,1977-4671,
4. Knight WA, Osborne CK, Yochmowitz MG, et al: Steroid hormone receptors in the management of human breast cancer. Ann Clin Res 12:202,1980-207,
5. Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献